The Latest Cardiac and Vascular News
NEW YORK–(BUSINESS WIRE)–BioSymetrics Inc., a biomedical AI company, today announced the formation of its Strategic Advisory Board (SAB). The newly-formed SAB will work closely with BioSymetrics’ leadership team to further the company’s mission of advancing healthcare and R&D innovation via machine learning and integrated analytics. The SAB is comprised of […]
ZUG, Switzerland, May 23, 2018 /PRNewswire/ — Drug developer Berlin Cures today announced the formation of a Scientific Advisory Board (SAB) and the appointment of its first two members, Prof. Beda M. Stadler and Prof. Wilhelm Vetter, to help advance the clinical development of BC 007, the first drug designed to target the autoimmune cause of heart failure as […]
